Cargando…

TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation

The TMEM127 gene encodes a transmembrane protein of poorly known function that is mutated in pheochromocytomas, neural crest-derived tumors of adrenomedullary cells. Here, we report that, at single-nucleus resolution, TMEM127-mutant tumors share precursor cells and transcription regulatory elements...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Qianjin, Cheng, Zi-Ming, Gonzalez-Cantú, Hector, Rotondi, Matthew, Huelgas-Morales, Gabriela, Ethiraj, Purushoth, Qiu, Zhijun, Lefkowitz, Jonathan, Song, Wan, Landry, Bethany N., Lopez, Hector, Estrada-Zuniga, Cynthia M., Goyal, Shivi, Khan, Mohammad Aasif, Walker, Timothy J., Wang, Exing, Li, Faqian, Ding, Yanli, Mulligan, Lois M., Aguiar, Ricardo C.T., Dahia, Patricia L.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637630/ https://www.ncbi.nlm.nih.gov/pubmed/37659079 http://dx.doi.org/10.1016/j.celrep.2023.113070

Ejemplares similares

A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions
por: Estrada-Zuniga, Cynthia M., et al.
Publicado: (2022)

Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane Dynamics
por: Walker, Timothy J., et al.
Publicado: (2023)

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
por: Qin, Yuejuan, et al.
Publicado: (2010)

OR29-5 New Insights into the Genotype/Phenotype Profile of TMEM127 Germline Mutations
por: Armaiz-Pena, Gustavo, et al.
Publicado: (2019)

SUN-138 Functional Characterization of Tumor-Associated Germline TMEM127 Variants Reveals Novel Insights into Membrane Topology and Protein Trafficking
por: Flores, Shahida, et al.
Publicado: (2020)

Pheochromocytomatosis associated with a novel TMEM127 mutation
por: Yu, Run, et al.
Publicado: (2017)

The tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific manner
por: Srikantan, Subramanya, et al.
Publicado: (2019)

GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
por: Mulligan, Lois M.
Publicado: (2019)

Identification of a TMEM127 variant in a patient with paraganglioma and acromegaly
por: Stütz, Beryl, et al.
Publicado: (2020)

Novel TMEM127 Variant Associated to Bilateral Phaeochromocytoma with an Uncommon Clinical Presentation
por: Fernández-Pombo, Antía, et al.
Publicado: (2019)

Novel germline variant of TMEM127 gene in a patient with familial pheochromocytoma
por: Saitoh, Kohei, et al.
Publicado: (2017)

Mutation and deletion analysis of GFRα-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours
por: Gimm, O, et al.
Publicado: (1999)

Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2
por: Wagner, Simona M., et al.
Publicado: (2012)

Alternative splicing results in RET isoforms with distinct trafficking properties
por: Richardson, Douglas S., et al.
Publicado: (2012)

Inhibition of IKKβ by celastrol and its analogues – an in silico and in vitro approach
por: Veerappan, Karpagam, et al.
Publicado: (2016)

miRNA-23b-5p affects the proliferation, migration and invasion of osteosarcoma by targeting TMEM127
por: Zu, Dan, et al.
Publicado: (2022)

Simultaneous Occurrence of Germline Pathogenic Allele Variants of TMEM127 and TP53 in a Brazilian Family With Li-Fraumeni Syndrome
por: Lima, Jose Viana, et al.
Publicado: (2021)

MYC, mitochondrial metabolism and O-GlcNAcylation converge to modulate the activity and subcellular localization of DNA and RNA demethylases
por: Lin, An-Ping, et al.
Publicado: (2022)

RET kinase inhibitors for RET-altered thyroid cancers
por: Vodopivec, Danica M., et al.
Publicado: (2022)

Precision therapy for RET-altered cancers with RET inhibitors
por: Thein, Kyaw Z., et al.
Publicado: (2021)

Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization
por: Schmutzler, Brian S, et al.
Publicado: (2011)

Selective RET kinase inhibition for patients with RET-altered cancers
por: Subbiah, V, et al.
Publicado: (2018)

Regulation of PD-L1 expression is a novel facet of cyclic-AMP-mediated immunosuppression
por: Sasi, Binu, et al.
Publicado: (2020)

Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.
por: Santoro, M., et al.
Publicado: (1993)

N(6)-methyladenosine-dependent pri-miR-17-92 maturation suppresses PTEN/TMEM127 and promotes sensitivity to everolimus in gastric cancer
por: Sun, Yiting, et al.
Publicado: (2020)

RET signaling pathway and RET inhibitors in human cancer
por: Regua, Angelina T., et al.
Publicado: (2022)

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
por: Rosen, Ezra Y., et al.
Publicado: (2022)

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
por: Solomon, Benjamin J., et al.
Publicado: (2020)

Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma
por: Dias-Santagata, Dora, et al.
Publicado: (2020)

Novel TMEM98 mutations in pedigrees with autosomal dominant nanophthalmos
por: Khorram, David, et al.
Publicado: (2015)

Volume 127 - Contents
Publicado: (2005)

Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers
por: Adashek, Jacob J., et al.
Publicado: (2021)

Precision oncology with selective RET inhibitor selpercatinib in RET-rearranged cancers
por: Gouda, Mohamed A., et al.
Publicado: (2023)

Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
por: Rosen, Ezra Y., et al.
Publicado: (2022)

Finding the bottom and using it: Offsets and sensitivity in the detection of low intensity values in vivo with 2-photon microscopy
por: Sandoval, Ruben M., et al.
Publicado: (2014)

The Tumour Suppressor TMEM127 Is a Nedd4-Family E3 Ligase Adaptor Required by Salmonella SteD to Ubiquitinate and Degrade MHC Class II Molecules
por: Alix, Eric, et al.
Publicado: (2020)

The RET gene encodes RET protein, which triggers intracellular signaling pathways for enteric neurogenesis, and RET mutation results in Hirschsprung's disease
por: Bhattarai, Chacchu, et al.
Publicado: (2022)

Magnetic dipole moment of $^{127}$Sb by NMR/ON
por: Booth, M, et al.
Publicado: (1992)

Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer
por: Wirth, Lori J., et al.
Publicado: (2019)

127th SPSC Meeting
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pn23lqirj8vt4ihq6c91gd5kn2